Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Significant shoulder pain and movement restriction within a couple of hours of receiving vaccine; Significant shoulder pain and movement restriction within a couple of hours of receiving vaccine; This is a spontaneous report received from a Consumer or other non HCP. A 58-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 01Oct2025 at 11:00 as dose 1, single (Batch/Lot number: unknown) at the age of 58 years for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 01Oct2025 at 11:00 as dose number unknown, single for influenza immunisation. The patient's relevant medical history included: "Drug allergy" (unspecified if ongoing). There were no concomitant medications. The following information was reported: ARTHRALGIA (non-serious), MOBILITY DECREASED (non-serious) all with onset 01Oct2025 at 12:00, outcome "not recovered" and all described as "Significant shoulder pain and movement restriction within a couple of hours of receiving vaccine". Therapeutic measures were taken as a result of arthralgia, mobility decreased. Additional information: The suspected vaccines were administered at a workplace clinic. The patient didn't receive any other vaccines with 4 weeks prior to the suspected vaccines. Treatment received for the adverse event included ice and Tylenol. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Drug allergy